Lundbeck was founded by Hans Lundbeck in Copenhagen more than 100 years ago.
We are approximately 5,400 employees worldwide.
Our largest shareholder is the Lundbeck Foundation owning approximately 70%.
Our products are registered in more than 100 countries globally.
Number of years that we have been building our neuroscience expertise.
Our portfolio of products reaches more than 8 million people on a daily average.
We are headquartered in Denmark and located in more than 50 countries around the world. We have production facilities in Denmark, France, and Italy, and research centers in Denmark and US.
We have employees in more than 50 countries, and employ approximately 5,400 people across the value chain.
In 1999, Lundbeck’s shares were listed on Nasdaq Copenhagen. Our largest shareholder is the Lundbeck Foundation, which holds approximately 70% of the shares. The Foundation annually grants about DKK 500 million to support medical research and educational and communication activities.
Our 2022 revenue reached a total of DKK 18.2 billion.
Our largest markets are US, China, Canada, Spain, Italy, France, Japan, Brazil, Australia and South Korea.
In 2022, our total revenue from strategic brands was DKK 12.1 billion.
Lundbeck has developed some of the world’s most widely prescribed therapies.
Our products - the proud results of years of research.
Take your next career step with Lundbeck.